Stem Cells as New Drug Candidates

Cord tissue mesenchymal stem cells hold great potential to address a variety of unmet healthcare and cosmetic needs. Bright cell currently is the sponsor of multiple clinical trials to evaluate the safety and efficacy of cord tissue mesenchymal stem cells in cosmetic or medical conditions. 

Our cutting-edge stem cell technologies can use cord tissue mesenchymal stem cells as a drug delivery platform to broaden the spectrum of applications of these stem cells in the future.  

Our state-of-the-art GMP facilities and experienced team enable us to produce high-quality stem cell products which meet the pharmaceutical grade, as required in clinical trials. We can also leverage of experience and expertise to help others in the cell therapy field and provide services as a contractor development and manufacturing organization (CDMO).

We understand the complex nature of stem cells. There are numerous scientific questions about stem cells are still waiting to be answered. Bright cell believes that innovation and discovery come from the deep understanding of the mechanisms underlying the stem cells' actions. Therefore, we always emphasize the importance of basic research and take the challenges to decipher the scientific elements of stem cells.